The parathyroid hormone, its fragments and analogues--potent bone-builders for treating osteoporosis (Q34074905)

30 July 2017

1 reference

title

The parathyroid hormone, its fragments and analogues--potent bone-builders for treating osteoporosis (English)

1 reference

30 July 2017

0 references

Whitfield J

1

1 reference

30 July 2017

Morley P

series ordinal

2

1 reference

30 July 2017

Willick G

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

1293-1315

1 reference

The diagnosis and treatment of osteoporosis: future prospects

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Emerging insights into the role of calcium ions in osteoclast regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Failure to detect the extracellular calcium-sensing receptor (CasR) in human osteoblast cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Expression of extracellular calcium (Ca2 + o)-sensing receptor in the clonal osteoblast-like cell lines, UMR-106 and SAOS-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Functional gap junctions between osteocytic and osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

The genetic transformation of bone biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Cytokines, bone remodeling, and estrogen deficiency: a 1998 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Modelling G-protein-coupled receptors for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Parathyroid hormone and parathyroid hormone-related peptide inhibit the apical Na+/H+ exchanger NHE-3 isoform in renal cells (OK) via a dual signaling cascade involving protein kinase A and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Dual signaling and ligand selectivity of the human PTH/PTHrP receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: implications for design of signal-specific PTH ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Stemming bone loss by suppressing apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

The Induction of Osteopetrotic Changes in Hypophysectomized, Thyroparathyroidectomized, and Intact Rats of Various Ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Lactam formation increases receptor binding, adenylyl cyclase stimulation and bone growth stimulation by human parathyroid hormone (hPTH)(1-28)NH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Comparison of the abilities of human parathyroid hormone (hPTH)-(1-34) and [Leu27]-cyclo(Glu22-Lys26)-hPTH-(1-31)NH2 to stimulate femoral trabecular bone growth in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Stimulation of new bone formation by direct transfer of osteogenic plasmid genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Estrogen via the estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Multipotential cells in the bone marrow stroma: regulation in the context of organ physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Temporal expression of PTHrP during endochondral bone formation in mouse and intramembranous bone formation in an in vivo rabbit model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Phosphorylation at the cyclin-dependent kinases site (Thr85) of parathyroid hormone-related protein negatively regulates its nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

The nucleolar targeting signal (NTS) of parathyroid hormone related protein mediates endocytosis and nucleolar translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Bone matters: are density increases necessary to reduce fracture risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Adverse effects of an active fragment of parathyroid hormone on rat hippocampal organotypic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

Suggestive Linkage of the Parathyroid Receptor Type 1 to Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

17β-Estradiol Potently Suppresses cAMP-induced Insulin-like Growth Factor-I Gene Activation in Primary Rat Osteoblast Cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1293

10.1517/13543784.9.6.1293

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference